SLN Shares Outstanding History



Below is a table of the SLN shares outstanding history going back to 9/8/2020:

Date SLN Shares Outstanding
9/8/202017.91M

Also see: SLN Market Cap History
SLN YTD Return
Mouse over chart for data details
9/8/2020 ...9/8/2020
Silence Therapeutics is a biotechnology company focused on discovering and developing molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes thought to play a role in the pathology of diseases with unmet medical need. Co.'s wholly owned pipeline is focused in three therapeutic areas of unmet need: cardiovascular disease, hematology and rare diseases. Co.'s wholly owned product candidates are: SLN360, which is an siRNA molecule designed for the treatment of cardiovascular disease associated with elevated Lp(a), a lipoprotein in the blood; and SLN124, which is an siRNA molecule designed to treat erythropoiesis. We show 1 historical shares outstanding datapoints in our coverage of SLN's shares outstanding history.

Understanding the changing numbers of SLN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SLN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SLN by allowing them to research SLN shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree SLN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Silence Therapeutics (SLN) is categorized under the Miscellaneous sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

SLNA Shares Outstanding History
SLVR Shares Outstanding History
SLX Shares Outstanding History
SMAP Shares Outstanding History
SMDV Shares Outstanding History
SMFR Shares Outstanding History
SMIH Shares Outstanding History
SMIN Shares Outstanding History
SMLF Shares Outstanding History
SMLL Shares Outstanding History
More Miscellaneous companies »

 

SLN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.